Search
Skip to Search Results- 1Ahmad, Rafiq
- 1Berke, Sheldon S
- 1Bernard-Gauthier, Vadim
- 1Clifford, Alison H.
- 1DeSilva, Alan D
- 1Kondapi, Venkata Pavan Kumar
-
Development of a Targeted Adenoviral Vector Expressing HSV-TK for use in Breast Cancer Gene Therapy and Analysis through Positron Emission Tomography
DownloadFall 2012
While adenoviral (Ad) vectors are the most commonly used gene delivery vector for human gene therapy, improvements must be made to increase Ad specificity to tumors if they are to be used for cancer gene therapy. Our goal is to target adenoviral vectors to breast cancer (BrCa) cells to induce...
-
Development of novel compounds for the molecular imaging of hypoxia: 18F-labeled nitroimidazoles and hypoxia inducible factor 1 alpha (HIF-1a)-targeting compounds
DownloadSpring 2023
Imaging of hypoxia has been previously achieved using positron emission tomography (PET) with radiotracers such as [18F]fluoroazomycin arabinoside ([18F]FAZA) [1] or [18F]fluoromisonidazole ([18F]FMISO) [2]. These typical nitroimidazole containing compounds are reductively trapped in hypoxic...
-
Does 18F-Fluodordeoxyglucose Positron Emission Tomography (PET) Correlate with Disease Activity in Patients who are Receiving Treatment for Giant Cell Arteritis (GCA): a Systematic Review and Meta-Analysis.
DownloadSpring 2023
Introduction: The utility of obtaining follow up 18-F fluorodeoxyglucose positron emission tomography (FDG PET) imaging in patients with giant cell arteritis (GCA) is unclear. We performed a systematic review and meta-analysis to determine how often vascular FDG PET uptake improves or normalizes...
-
Exploiting the Enhanced Permeability and Retention Effect for the Targeting of Tumors with 18F-SiFA Polymer Nanoparticles
DownloadFall 2017
Over the last several decades great progress has been made in cancer diagnosis and detection. One foundation of this progress has been improved imaging technologies. Among the most promising imaging technologies for cancer detection is Positron Emission Tomography (PET). PET imaging allows for...
-
Molecular imaging of cyclooxygenase-2 (COX-2) and autotaxin (ATX) in cancer using positron emission tomography (PET)
DownloadFall 2020
Positron emission tomography (PET) relies on the use of β+-emitting radionuclide-bearing molecules congregating and decaying at a specific site of interest. Use of these molecules, called radiotracers, which target common tumor characteristics has become a pillar in the diagnosis of cancer and...
-
Radiosynthesis and Optimization of 18F-Fluorinated GW2580 Derivatives as A Dual Trk/CSF-1R Radiotracer for Potential Use in PET Imaging
DownloadFall 2018
As one of the medical imaging modalities applied in clinical diagnosis of various diseases, positron emission tomography (PET) is used to non-invasively visualize cellular and molecular changes that are occurring in the human body. Fluorine-18 [18F] is the most widely used radionuclide for...
-
Tracer Development for the Molecular Imaging of Breast Cancer: Synthesis and Biological Evaluation of C-3 Modified 2,5-Anhydro-D-mannitol Derivatives as Potential Tracer Molecules
DownloadSpring 2016
Mammography is the most frequently used imaging method for the detection of breast cancer. Despite the key role of mammography in the breast cancer detection, false-negative diagnosis by mammograms ranges from 4 to 34%. Positron emission tomography (PET), a tracer based molecular imaging method...